alexa Emiko Furukawa |
ISSN: 2327-5073

Clinical Microbiology: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Emiko Furukawa

 Division of Clinical Infectious Disease & Chemotherapy, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Biography

 Emiko Furukawa is currently in Division of Clinical Infectious Disease & Chemotherapy, Tohoku Medical and Pharmaceutical University, Sendai, Japan.  He has published research papers and articles in reputed journals and has various other achievements in the related studies. He has extended his valuable service towards the scientific community with her extensive research work. 

Research Interest

 Piperacillin, Levofloxacin, oprD, Sodium zinc histidine dihydrolipoyl histidinate.

Publications

Exposure to Reactive Oxygen Species and Piperacillin Leads to Multidrug Resistance in Pseudomonas aeruginosa PAO1

Sachiko Hayakawa, Emiko Furukawa, Masato Kawamura, Toshiaki Kikuchi, Taizou Hirano, Akira Watanabe and Shigeru Fujimura

Research Article: Clin Microbiol

DOI: 10.4172/2327-5073.1000264

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords